News J&J's run of talc lawsuit setbacks continues A California jury has awarded $40m in damages to two women who sued Johnson & Johnson, claiming that its talc products caused ovarian cancer.
News GSK unit and AnaptysBio trade lawsuits over Jemperli A spat between GSK/Tesaro and AnaptysBio over cancer drug Jemperli has escalated into litigation, with both parties claiming breach of contract.
News Pfizer said to have matched Novo's $10bn bid for Metsera The battle for obesity drug developer Metsera rumbles on, with Pfizer reported to have now matched Novo Nordisk's $10 billion offer.
News Bidding war breaks out as Novo raises Metsera bid to $10bn Metsera has now received new takeover bids from both Pfizer and Novo Nordisk, and has plumped for a sweetened $10bn offer from the latter.
News Pfizer files another lawsuit against Metsera, Novo Nordisk Metsera says Novo Nordisk's takeover offer is superior to one filed by Pfizer, and the latter files a new lawsuit to try to force their deal through.
News Pfizer sues to block Novo Nordisk's Metsera takeover bid Pfizer has filed a lawsuit to block a rival, higher bid for obesity therapy developer Metsera from Novo Nordisk, claiming it is anti-competitive.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.